These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31895432)

  • 1. Use of Epidermal Growth Factor Receptor Inhibitor Erlotinib to Treat Palmoplantar Keratoderma in Patients With Olmsted Syndrome Caused by TRPV3 Mutations.
    Greco C; Leclerc-Mercier S; Chaumon S; Doz F; Hadj-Rabia S; Molina T; Boucheix C; Bodemer C
    JAMA Dermatol; 2020 Feb; 156(2):191-195. PubMed ID: 31895432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Inhibition of the Epidermal Growth Factor Receptor and Mammalian Target of Rapamycin Signaling Pathways in Olmsted Syndrome.
    Zhang A; Duchatelet S; Lakdawala N; Tower RL; Diamond C; Marathe K; Hill I; Richard G; Diab Y; Kirkorian AY; Watanabe F; Siegel DH; Hovnanian A
    JAMA Dermatol; 2020 Feb; 156(2):196-200. PubMed ID: 31895414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two for two: Dual therapy with erlotinib and acitretin for twins with severe keratoderma in Olmsted syndrome.
    Butala S; Phan S; Siegel DH; Carlberg V; Paller AS
    Pediatr Dermatol; 2023; 40(4):735-737. PubMed ID: 36709954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new TRPV3 missense mutation in a patient with Olmsted syndrome and erythromelalgia.
    Duchatelet S; Pruvost S; de Veer S; Fraitag S; Nitschké P; Bole-Feysot C; Bodemer C; Hovnanian A
    JAMA Dermatol; 2014 Mar; 150(3):303-6. PubMed ID: 24452206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olmsted Syndrome Caused by a Heterozygous p.Gly568Val Missense Mutation in TRPV3 Gene.
    Choi JY; Kim SE; Lee SE; Kim SC
    Yonsei Med J; 2018 Mar; 59(2):341-344. PubMed ID: 29436206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two familial cases of Olmsted-like syndrome with a G573V mutation of the TRPV3 gene.
    Zhi YP; Liu J; Han JW; Huang YP; Gao ZQ; Yang Y; Wu RN
    Clin Exp Dermatol; 2016 Jul; 41(5):510-3. PubMed ID: 27273692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of
    Spitz KE; Chu L; Lawley LP
    JAAD Case Rep; 2022 Jul; 25():83-85. PubMed ID: 35789571
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of a heterozygous p.Gly568Val missense mutation in the TRPV3 gene in a Japanese patient with Olmsted syndrome: In silico analysis of TRPV3.
    Nagai H; Takaoka Y; Sugano A; Nakamachi Y; Kawano S; Nishigori C
    J Dermatol; 2017 Sep; 44(9):1059-1062. PubMed ID: 28391651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFR Signaling Is Overactive in Pachyonychia Congenita: Effective Treatment with Oral Erlotinib.
    Basset J; Marchal L; Hovnanian A
    J Invest Dermatol; 2023 Feb; 143(2):294-304.e8. PubMed ID: 36116508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exome sequencing reveals mutations in TRPV3 as a cause of Olmsted syndrome.
    Lin Z; Chen Q; Lee M; Cao X; Zhang J; Ma D; Chen L; Hu X; Wang H; Wang X; Zhang P; Liu X; Guan L; Tang Y; Yang H; Tu P; Bu D; Zhu X; Wang K; Li R; Yang Y
    Am J Hum Genet; 2012 Mar; 90(3):558-64. PubMed ID: 22405088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype‒Phenotype Correlation of TRPV3-Related Olmsted Syndrome.
    Zhong W; Hu L; Cao X; Zhao J; Zhang X; Lee M; Wang H; Zhang J; Chen Q; Feng C; Duo L; Wang X; Tang L; Lin Z; Yang Y
    J Invest Dermatol; 2021 Mar; 141(3):545-554. PubMed ID: 32795529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olmsted syndrome in an Iranian boy with a new de novo mutation in TRPV3.
    Kariminejad A; Barzegar M; Abdollahimajd F; Pramanik R; McGrath JA
    Clin Exp Dermatol; 2014 Jun; 39(4):492-5. PubMed ID: 24758389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olmsted syndrome with erythromelalgia caused by recessive transient receptor potential vanilloid 3 mutations.
    Duchatelet S; Guibbal L; de Veer S; Fraitag S; Nitschké P; Zarhrate M; Bodemer C; Hovnanian A
    Br J Dermatol; 2014 Sep; 171(3):675-8. PubMed ID: 24606194
    [No Abstract]   [Full Text] [Related]  

  • 14. Olmsted syndrome: clinical, molecular and therapeutic aspects.
    Duchatelet S; Hovnanian A
    Orphanet J Rare Dis; 2015 Mar; 10():33. PubMed ID: 25886873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Painful Palmoplantar Keratoderma Related to Pachyonychia Congenita Using EGFR Inhibitors.
    Greco C; Ponsen AC; Leclerc-Mercier S; Schlatter J; Cisternino S; Boucheix C; Bodemer C
    Biomedicines; 2022 Apr; 10(4):. PubMed ID: 35453591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olmsted Syndrome: Response to erlotinib therapy and genotype/phenotype correlation.
    Noakes R
    Australas J Dermatol; 2021 Aug; 62(3):445-446. PubMed ID: 34227679
    [No Abstract]   [Full Text] [Related]  

  • 17. Recurrent heterozygous missense mutation, p.Gly573Ser, in the TRPV3 gene in an Indian boy with sporadic Olmsted syndrome.
    Lai-Cheong JE; Sethuraman G; Ramam M; Stone K; Simpson MA; McGrath JA
    Br J Dermatol; 2012 Aug; 167(2):440-2. PubMed ID: 22835024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRPV3 mutants causing Olmsted Syndrome induce impaired cell adhesion and nonfunctional lysosomes.
    Yadav M; Goswami C
    Channels (Austin); 2017 May; 11(3):196-208. PubMed ID: 27754757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of clinical feature and genetic basis of a rare case with Olmsted syndrome].
    Lu J; Hu R; Liu L; Ding H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Jul; 38(7):674-677. PubMed ID: 34247376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective cathepsin Z affects EGFR expression and causes autosomal dominant palmoplantar keratoderma.
    Malovitski K; Sarig O; Feller Y; Bergson S; Assaf S; Mohamad J; Pavlovsky M; Giladi M; Sprecher E
    Br J Dermatol; 2023 Aug; 189(3):302-311. PubMed ID: 37210216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.